Table 3.
Treatment and patient outcome
| Patient No. | Age, y | Sex | Tumor Location | Extent of Resection | Radiation Dose (Gy) | Tumor Progression, y | Survival Status, ya |
|---|---|---|---|---|---|---|---|
| 1 | 20 | M | R Temporal | GTR(Lob) | None | No, 20.4 | Alive, 20.4 |
| 2 | 47 | F | Third Ventricle | GTR | None | No, 27.0 | Alive, 27.0 |
| 3 | 32 | M | L Temp/Occ | GTR | None | No, 26.5 | Alive, 26.5 |
| 4 | 21 | F | L Temporal | GTR | None | No, 25.8 | Alive, 25.8 |
| 5 | 46 | M | L Front/Temp | GTR | None | No, 25.1 | Alive, 25.9 |
| 6 | 21 | F | L Thalamus | GTR | None | No, 25.6 | Alive, 25.6 |
| 7 | 40 | F | L Temporal | GTR(Lob) | None | No, 24.5 | Alive, 24.5 |
| 8 | 22 | M | L Frontal | STR | None | No, 24.9 | Alive, 24.9 |
| 9 | 40 | F | R Thalamus | STR | None | Yes, 0.1 | Alive, 20.2 |
| 10 | 35 | F | L Occipital | GTR(Lob) | None | No, 21.6 | Alive, 21.6 |
| 11 | 31 | F | L Frontal | Bx | 50.4 Gy | No, 10.1 | Alive, 18.8 |
| 12 | 22 | M | R Temporal | GTR | None | No, 21.1 | Alive, 21.1 |
| 13 | 41 | F | R Frontal | GTR | None | No, 8.1 | Alive, 18.7 |
| 14 | 37 | F | L Thalamus | STR | None | No, 17.7 | Alive, 18.5 |
| 15 | 32 | F | R Temporal | GTR | None | No, 14.2 | Alive, 18.2 |
| 16 | 31 | F | R Parietal | STR | None | No, 14.9 | Alive, 18.3 |
| 17 | 21 | F | L Thalamus | Bx | 50.4 Gy | No, 2.1 | Dead, 2.2 |
| 18 | 37 | M | L Brainstem | STR | None | No, 17.1 | Alive, 17.1 |
| 19 | 32 | F | L Front/Temp | STR | None | No, 9.5 | Alive, 17.1 |
| 20 | 41 | M | Third Ventricle/Pineal | Bx | 50.4 Gy | No, 15.9 | Dead, 16.1 |
Patient No., patient number; M, male; R, right; GTR, gross total resection; lob, lobectomy performed at operation; F, female; L, left; STR, subtotal resection; Bx, biopsy.
aYears since study entry.